Sofidel America will invest in a new state-of-the-art Valmet Advantage ThruAir tissue line to expand its production of ultra-premium tissue products in North America. The investment strengthens Sofidel’s U.S. presence and supports growing market demand for high-quality TAD (Through-Air-Dried) tissue.
Valmet will supply a complete tissue production line including mill engineering, stock preparation, the Advantage ThruAir 200 machine, automation systems (Valmet DNA DCS, IQ QCS, WMS), flow control, and Industrial Internet solutions. The line, with a width of 5.6 meters and an annual capacity of 75,000 tons, is designed for high efficiency, fiber savings, and top product quality.
The two companies have collaborated for over 30 years. Following the successful 2025 start-up of an Advantage DCT line in Circleville, Ohio, this new project marks Valmet’s largest full-scope tissue delivery to date.